The Status of Covid-19 Vaccines Hesitancy Two Years after the Rollout of COVID-19 Vaccines

Raphael Abolasom Kumah *

Ghana Health Service, Bono Regional Hospital, Sunyani, Ghana.

Abdul-Mumin Amankwa

College of Nursing and Allied Health Sciences, Nalerigu, Ghana.

Abdul-Wadudu Faridu

Department of Environmental and Occupational Health, University for Development Studies, Ghana.

*Author to whom correspondence should be addressed.


Abstract

Two years have passed since the world was hit by the COVID-19 pandemic, and with the roll-out of vaccines, the hope for a return to normalcy has been rekindled. However, vaccine hesitancy remains a challenge in many parts of the world, as some individuals remain skeptical about the safety of the vaccines. A far-flung of literature reviewed indicates that, vaccines are essential in disease prevention, yet, elements within populations are still hesitant for some, due to the lack of confidence in the effectiveness of the vaccines, and some, for religious beliefs among others to accept COVID-19 vaccines. Although, COVID-19 as declared by the World Health Organisation is no more a pandemic, the refusal to accept the vaccines could once again jeopardize our health system if another pandemic hit us. This paper examines whether vaccine hesitancy has changed two years after the roll-out of COVID-19 vaccines.

Keywords: COVID-19, vaccine, hesitancy, acceptance


How to Cite

Kumah , Raphael Abolasom, Abdul-Mumin Amankwa, and Abdul-Wadudu Faridu. 2023. “The Status of Covid-19 Vaccines Hesitancy Two Years After the Rollout of COVID-19 Vaccines”. Asian Journal of Research in Nursing and Health 6 (1):293-96. https://journalajrnh.com/index.php/AJRNH/article/view/129.

Downloads

Download data is not yet available.

References

World Health Organisation. Vaccine Hesitancy: A Growing Challenge for Immunization Programmes; 2015.

Asumah MN, Satapathy P, Abubakari A, et al. Measles outbreak in northern ghana highlights vaccine shortage crisis. New Microbes New Infect. 2023;53.

Asumah MN, Padhi BK, Sinha A. Rising cases of cholera in Ethiopia: A need for sustainable wash practices? Int J Surg. 2023;109:608–609.

Goel K, Sen A, Satapathy P, et al. Rabies on rise in Africa amid COVID and monkeypox: A global health concern. QJM An Int J Med.

Fajar JK, Sallam M, Soegiarto G, et al. Global prevalence and potential influencing factors of COVID-19 vaccination hesitancy: A Meta-analysis. Vaccines. 2022;10:1356.

Asumah MN, Abubakari A, Fosu B, et al. Determinants of COVID-19 vaccine acceptance and hesitancy among healthcare professionals in the Kintampo North Municipality, Bono East Region, Ghana. Ghana Med J. 2022;56:152–159.

Gupta S, Cantor J, Simon KI, et al. Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States: Study examines role of COVID-19 vaccines and deaths averted in the United States. Health Aff. 2021;40: 1465–1472.

Mohammed A-S, Asumah MN, Padhi BK, et al. Predictors of SARS-CoV-2 vaccine uptake among health professionals: A cross-sectional study in Ghana. Vaccines. 2023;11:190.

Larson HJ, Gakidou E, Murray CJL. The vaccine-hesitant moment. N Engl J Med. 2022;387:58–65.

MacDonald NE. SAGE working group on vaccine hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015;33:4161–4164.

AlShurman B, Butt ZA. Proposing a new conceptual syndemic framework for COVID-19 vaccine hesitancy: A narrative review. Int J Environ Res Public Health. 2023;20:1561.

Kumar D, Chandra R, Mathur M, et al. Vaccine hesitancy: Understanding better to address better. Isr J Health Policy Res. 2016;5:1–8.

Arede M, Bravo-Araya M, Bouchard É, et al. Combating vaccine hesitancy: Teaching the next generation to navigate through the post truth era. Front public Heal. 2019;6: 381.

Mose A, Haile K, Timerga A. COVID-19 vaccine hesitancy among medical and health science students attending Wolkite University in Ethiopia. PLoS One. 2022;17:e0263081.

Dhama K, Sharun K, Tiwari R, et al. COVID-19 vaccine hesitancy–reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccin Immunother. 2021; 17:3495–3499.

Dzantor EK, Asumah MN, Inusah A, et al. Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana. Nurs Open. 2023;10: 1785–1793.

Nuwarda RF, Ramzan I, Weekes L, et al. Vaccine hesitancy: Contemporary issues and historical background. Vaccines. 2022;10:1595.

Peretti-Watel P, Seror V, Cortaredona S, et al. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20: 769–770.

Al‐Amer R, Maneze D, Everett B, et al. COVID‐19 vaccination intention in the first year of the pandemic: A systematic review. J Clin Nurs. 2022;31:62–86.

Sallam M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines. 2021; 9:160.